Published on Feb 25, 2017
Dr. Daniel Kantor talks with Dr. Kottil Rammohan, Professor of Neurology at the University of Miami School of Medicine about Ocrelizumab and the risk for infections.
Click above. Listen to Learn
Click here to receive MS news via e-mail
MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews